Pharmaceutical companies continue to adapt to regulations like the FDA’s Drug Supply Chain Security Act (DSCSA) and 21 CFR Part 11. At the same time, their supply chain needs to operate more efficiently to compete in a growing marketplace. That’s why more and more manufacturers are looking at labeling to provide an edge in the face of these challenges.

The pharmaceutical supply chain is highly complex, with many steps, as ingredients are often shipped in bulk, repackaged and reshipped before they find their way to the manufacturer producing the branded end-products. Multiple tiers of suppliers and wholesalers are often involved. Oftentimes, borders are crossed. Labeling is essential to smooth the flow of the pharmaceutical supply chain, where problems can arise at any juncture in the chain, or may “wait” to become manifest only in a finished product.